<Disease><Name>BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT (BARTS5)</Name><Synonym /><OMIM><Number>300971</Number><URL>http://omim.org/entry/300971</URL></OMIM><Orphanet><Number>112</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=112</URL></Orphanet><Protein><Number>Melanoma-associated antigen D2</Number><URL>http://www.uniprot.org/uniprot/Q9UNF1</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>Xp11.21</Gene><ICD>E26.8</ICD><Summary>rare;X-linked recessive;mutation in the MAGED2 gene;Types of Bartter syndrome:;- Type I (OMIM 601678);- Type II (OMIM 241200);- Type III (OMIM 607364), ;classic Bartter syndrome;- Type IVA (OMIM 602522);- Type IVB (OMIM 613090);- Type V (OMIM 300971)</Summary><Symptoms><symtomp><id>1922</id><symptom>nephrocalcinosis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3205</id><symptom>polyhydramnion (maternal)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2005</id><symptom>polyuria</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>2172</id><symptom>prematurity, premature delivery</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2138</id><name>Sodium</name><specimen>urine</specimen><value /><min>40.00</min><max>220.00</max><unit>mmol/24h</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>2139</id><name>Potassium</name><specimen>urine</specimen><value /><min>3.00</min><max>125.00</max><unit>mmol/24h</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>798</id><name>Aldosterone</name><specimen>plasma</specimen><value /><min>5.00</min><max>60.00</max><unit>ng/dl</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>799</id><name>Aldosterone</name><specimen>plasma</specimen><value /><min>1.00</min><max>160.00</max><unit>ng/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>795</id><name>Calcium</name><specimen>urine</specimen><value>increased</value><min>1.30</min><max>3.80</max><unit>mmol/24h</unit><age>child</age><method /><comment /></metabolite><metabolite><id>922</id><name>Calcium</name><specimen>serum</specimen><value>increased</value><min>2.10</min><max>2.20</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>727</id><name>Chloride</name><specimen>sweat</specimen><value>increased</value><min>20.00</min><max>30.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>731</id><name>Chloride</name><specimen>serum</specimen><value>decreased</value><min>97.00</min><max>110.00</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>794</id><name>Chloride</name><specimen>serum</specimen><value>decreased</value><min>98.00</min><max>106.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1022</id><name>Chloride</name><specimen>stool</specimen><value>decreased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>410</id><name>Potassium</name><specimen>serum</specimen><value>decreased</value><min>3.90</min><max>5.90</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>411</id><name>Potassium</name><specimen>serum</specimen><value>decreased</value><min>3.50</min><max>5.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>412</id><name>Potassium</name><specimen>serum</specimen><value>decreased</value><min>3.50</min><max>5.50</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>409</id><name>Sodium</name><specimen>serum</specimen><value>decreased</value><min>134.00</min><max>146.00</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>413</id><name>Sodium</name><specimen>serum</specimen><value>decreased</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>728</id><name>Sodium</name><specimen>sweat</specimen><value>decreased</value><min>20.00</min><max>30.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1105</id><name>Sodium</name><specimen>serum</specimen><value>decreased</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>5471</id><title>Bartter Syndrome</title><author>Bokhari SRA,</author><journal>StatPearls [Internet]</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Mansur A</co_aut></literature><literature><id>7283</id><title>Inherited salt-losing tubulopathy: an old condition but a new category of tubulopathy</title><author>Nozu K,</author><journal>Pediatr Int</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7284</id><title>Bartter and Gitelman syndromes: Questions of class</title><author>Besouw MTP,</author><journal>Pediatr Nephrol</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Kleta R, Bockenhauer D</co_aut></literature><literature><id>7288</id><title>Bartter syndrome: causes, diagnosis, and treatment</title><author>Cunha TDS,</author><journal>nt J Nephrol Renovasc Dis</journal><year>2018</year><book /><volume>11</volume><number>0</number><pages>291-301</pages><co_aut>Heilberg IP</co_aut></literature><literature><id>5504</id><title>Polyhydramnios, Transient Antenatal Bartters Syndrome, and MAGED2 Mutations</title><author>Laghmani K,</author><journal>N Engl J Med</journal><year>2016</year><book /><volume>374</volume><number>19</number><pages>1853-1863</pages><co_aut>et al.</co_aut></literature><literature><id>5505</id><title>Renal physiology: MAGED2 mutations in transient antenatal Bartter syndrome</title><author>Allison SJ</author><journal>Nat Rev Nephrol</journal><year>2016</year><book /><volume>12</volume><number>7</number><pages>377</pages><co_aut /></literature><literature><id>5506</id><title>NKCC2 activity is inhibited by the Bartters syndrome type 5 gain-of-function CaR-A843E mutant in renal cells</title><author>Carmosino M,</author><journal>Biol Cell</journal><year>2015</year><book /><volume>107</volume><number>4</number><pages>98-100</pages><co_aut>et al.</co_aut></literature><literature><id>5507</id><title>Amikacin-induced type 5 Bartter-like syndrome with severe hypocalcemia</title><author>Chrispal A,</author><journal>J Postgrad Med</journal><year>2009</year><book /><volume>55</volume><number>3</number><pages>208-210</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>